Each SF is also associated with a distinct pattern of mutations in other genes commonly detected in myeloid malignancies, as in the case of SRSF2 mutations with TET2 mutations in CMML and with RUNX1, IDH2, and ASXL1 mutations in AML. This evidence concerns the gene RUNX1 and myeloid neoplasm.